期刊文献+

腹主动脉旁淋巴引流区预防性放疗对中晚期合并盆腔淋巴结阳性宫颈癌的疗效

Therapeutic effect of prophylactic radiotherapy in para-aortic lymphatic drainage area for middle and advanced cervical cancer with positive pelvic lymph nodes
下载PDF
导出
摘要 目的探讨腹主动脉旁淋巴引流区预防性放疗对中晚期合并盆腔淋巴结阳性宫颈癌的疗效。方法选取2015年2月~2017年10月江西省妇幼保健院收治的81例中晚期合并盆腔淋巴结阳性宫颈癌患者作为研究对象,按照随机数表法分为对照组(40例)与研究组(41例),对照组采用以铂类为基础的化疗方案,研究组在此基础上实施腹主动脉旁淋巴引流区预防性放疗,比较两组疾病控制率、急性放化疗不良反应发生情况及生存率。结果研究组疾病控制率高于对照组,差异有统计学意义(P<0.05)。两组急性放化疗不良反应总发生率比较,差异无统计学意义(P>0.05)。研究组2、3年累计生存率高于对照组,差异有统计学意义(P<0.05)。结论中晚期合并盆腔淋巴结阳性宫颈癌临床治疗中,给予腹主动脉旁淋巴引流区预防性放疗的临床疗效较好,安全性较高,值得推广。 Objective To investigate the effect of prophylaxis radiotherapy in para-aortic lymphatic drainage area on middle and advanced cervical cancer with positive pelvic lymph nodes.Methods A total of 81 patients with advanced cervical cancer with pelvic lymph node positive admitted to Jiangxi maternal and child health hospital from February 2015 to October 2017 were selected as the research subjects.According to random number table method,they were divided into control group(40 cases)and study group(41 cases).The control group received platinum-based chemotherapy,and the study group received prophylactic radiotherapy in the para-aortic lymphatic drainage area on this basis.The disease control rate,the incidence of adverse reactions of acute radiotherapy and chemotherapy and the survival rate were compared between two groups.Results The disease control rate in the study group was higher than that in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).The 2-and 3-year cumulative survival rate in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusion In the clinical treatment of middle and advanced cervical cancer complicated with positive pelvic lymph nodes,prophylactic radiotherapy in the para-aortic lymphatic drainage area has good clinical efficacy and high safety,which is worthy of promotion.
作者 王亚男 曾四元 钟美玲 袁建晖 WANG Ya-nan;ZENG Si-yuan;ZHONG Mei-ling;YUAN Jian-hui(Department of Oncology,Jiangxi Maternal and Child Health Hospital,Jiangxi Province,Nanchang330000,China)
出处 《中国当代医药》 CAS 2021年第13期54-56,60,共4页 China Modern Medicine
基金 江西省卫生计生委科技计划项目(20195496)。
关键词 淋巴结 宫颈癌 腹主动脉旁淋巴引流区 预防性放疗 Lymph node Cervical cancer Para aortic lymphatic drainage area Prophylactic radiation
  • 相关文献

参考文献13

二级参考文献130

  • 1冯淑瑜,张彦娜,刘建刚.宫颈癌淋巴结转移的高危因素及预后分析[J].癌症,2005,24(10):1261-1266. 被引量:71
  • 2雍成升,鲍健,李继如,刘美琴,陈振东.CTCAE血糖异常评价标准在肿瘤化疗中的应用[J].安徽医药,2007,11(1):62-63. 被引量:3
  • 3陈雅卿,郑爱文,楼洪坤.ⅠB~ⅡB期前宫颈癌髂总淋巴结转移的临床分析[J].中华肿瘤防治杂志,2007,14(14):1097-1099. 被引量:8
  • 4H Joensuu,GD Demetri,MC Heinrich.7506 ORAL Up to 6 years follow-up of patients receiving imatinib mesylate (Glivec) to treat unresectable ormetastatic gastrointestinal stromal tumors (GISTs)[J].European Journal of Cancer Supplements,2007,5(4):404. 被引量:1
  • 5Jonathan Sleeman,Anja Schmidband Wilko Thiele.Tumor lymphatics[J].Seminars in Cancer Biology,2009,19(5):285-297. 被引量:1
  • 6RG Grundy,SH Wilne,KJ Robinson.Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years:Results of the first UKCCSG/SIOP CNS 9204 trial[J].European Journal of Cancer,2010,46(1):120-133. 被引量:1
  • 7I Ralph Edwards,Jeffrey K Aronson.Adverse drug reactions:definitions,diagnosis,and management[J].THE LANCET,2000,356(237):1255-1259. 被引量:1
  • 8Miller AB,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47(1):207-214. 被引量:1
  • 9Andy Trotti,A Dimitrios Colevas,Ann Setser,et al.CTCAE v3.0:Development of a Comprehensive Grading System for the Adverse Effects[J].Seminars in Radiation Oncology,2003,13(3):176-181. 被引量:1
  • 10Andy Trotti.The Evolution and Application of Toxicity Criteria[J].Seminars in Radiation Oncology,2002,12(Suppl 1):1-3. 被引量:1

共引文献380

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部